Bioceltech Therapeutics, Ltd.
PrivateLast Round
Series A
Jun 2, 2023
Total Funding Raised
$8M
Company Overview
Bioceltech Therapeutics, Ltd. is a biotechnology company that focuses on the development and application of immunotherapy, including CAR-T cell therapies for the treatment of hematologic neoplasms and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioceltech Therapeutics, Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Bioceltech Therapeutics, Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 2, 2023 | ||||
| Angel | Jan 4, 2018 |
Bioceltech Therapeutics, Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canica | Series A |
| Sandwater | Series A |
| Anlong Fund | Angel |
Bioceltech Therapeutics, Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioceltech Therapeutics, Ltd.'s valuation, stock price, and market status.